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The dosage compensation complex (DCC) in Drosophila melanogaster is responsible for up-regulating transcription
from the single male X chromosome to equal the transcription from the two X chromosomes in females. Visualization
of the DCC, a large ribonucleoprotein complex, on male larval polytene chromosomes reveals that the complex binds
selectively to many interbands on the X chromosome. The targeting of the DCC is thought to be in part determined by
DNA sequences that are enriched on the X. So far, lack of knowledge about DCC binding sites has prevented the
identification of sequence determinants. Only three binding sites have been identified to date, but analysis of their
DNA sequence did not allow the prediction of further binding sites. We have used chromatin immunoprecipitation to
identify a number of new DCC binding fragments and characterized them in vivo by visualizing DCC binding to
autosomal insertions of these fragments, and we have demonstrated that they possess a wide range of potential to
recruit the DCC. By varying the in vivo concentration of the DCC, we provide evidence that this range of recruitment
potential is due to differences in affinity of the complex to these sites. We were also able to establish that DCC binding
to ectopic high-affinity sites can allow nearby low-affinity sites to recruit the complex. Using the sequences of the
newly identified and previously characterized binding fragments, we have uncovered a number of short sequence
motifs, which in combination may contribute to DCC recruitment. Our findings suggest that the DCC is recruited to the
X via a number of binding sites of decreasing affinities, and that the presence of high- and moderate-affinity sites on
the X may ensure that lower-affinity sites are occupied in a context-dependent manner. Our bioinformatics analysis
suggests that DCC binding sites may be composed of variable combinations of degenerate motifs.
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Introduction
A mechanism for selecting and marking an entire
chromosome for coordinate regulation is central to the
process of dosage compensation. Genetic sex determination
in animals usually involves a pair of heterologous sex
chromosomes and leads to a chromosome imbalance between
males and females. Consequently, the process of dosage
compensation is necessary to ensure equal expression of sex
chromosome–linked genes. Studies in different species have
revealed that dosage compensation may be achieved through
different modes of chromosome-wide transcriptional regu-
lation, and that different means of targeting the selected
chromosome may be employed (reviewed in [1]). In all cases,
the chromosome or chromosomes to be regulated are marked
by the presence of speciﬁc protein or ribonucleoprotein
complexes as well as alterations in chromatin structure.
In mammals, dosage compensation is achieved by the
inactivation of one of the two X chromosomes in females. The
selection of this chromosome for inactivation is initiated
from a single locus, the X inactivation center (XIC) on the X
(reviewed in [2]). This locus encodes the non-coding Xist RNA
whose accumulation is necessary and sufﬁcient to mark the
chromosome for inactivation [3]. In the worm Caenorhabditis
elegans, gene expression from both X chromosomes in
hermaphrodites is reduced to about half when compared to
expression of the single X chromosomes in males (reviewed in
[4]). This is achieved by the binding of a multi-subunit dosage
compensation complex (DCC) along the entire length of both
X chromosomes. In this case, the selection of the chromo-
somes is not due to a single locus, but is thought to involve
multiple recognition sites for the DCC [5,6]. In the ﬂy
Drosophila melanogaster, dosage compensation is also achieved
by a large ribonucleoprotein complex (reviewed in [7–9]). The
Drosophila DCC, however, is recruited to the single male X
chromosome and leads to an approximate two-fold increase
in transcription of many X-linked genes [10,11]. The selection
of the X in ﬂies uses a system with similarities to both
mechanisms mentioned above, relying in part on the
expression and accumulation of two non-coding RNAs from
the X and in part on the presence of speciﬁc recruitment sites
distinguishing the X from other chromosomes [12,13].
The DCC of D. melanogaster contains at least ﬁve proteins
and one of two non-coding RNAs that are all essential for
male survival. The three male-speciﬁc lethal proteins MSL1
[14], MSL2 [15], and MSL3 [16] are thought to provide
structural and regulatory functions [17,18] whereas the males
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contribute acetyltransferase and helicase activity, respec-
tively. The function of the two non-coding RNAs, roX1 (RNA
on the X) and roX2, is so far unknown. However, all the
structural components and both enzymatic activities, as well
as at least one RNA, are required for proper targeting of the
DCC to the male X and its distribution over the entire
chromosome [16,19,21–23]. MSL2 is the only component that
is strictly male speciﬁc [24], and its presence in the nucleus
leads to the stabilization of other complex components and
the accumulation of the DCC on the X chromosome [25]. In
females, the translation of MSL2 mRNA is inhibited by the
Sex-lethal protein (SXL) and the complex does not form
[26,27]. However, unregulated ectopic expression of MSL2
leads to DCC formation and binding to both X chromosomes
[25,27,28]. This fact has allowed detailed study of the
mechanism of DCC targeting and distribution in Drosophila.
Immunostaining of polytene chromosomes from the
salivary glands of Drosophila larvae allows the visualization of
proteins on interphase chromatin and has been used
extensively in the study of dosage compensation [29]. The
binding pattern of the DCC is well deﬁned, being restricted to
interbands on the male X chromosome [28] (Figure 1A).
Mutations in DCC components change this binding pattern.
If MSL1 or MSL2 are mutated, the entire complex is lost from
the X chromosome. Mutations in the remaining components
lead to binding of partial complexes to a deﬁned subset of
sites [22,28,30]. This is illustrated in Figure 1A, which shows
the distribution of MSL1 on polytene chromosomes of female
larvae expressing MSL2 ectopically and carrying mutations in
mle, msl-3, and mof. The subset of binding sites remaining in
the msl-3 background was originally termed ‘‘chromatin entry
sites’’ [31]. A longstanding model for how the DCC is localized
to the X assumed that these distinctive loci served as primary
recruitment sites for the DCC from which the complex
distributes to less-deﬁned chromatin by spreading in cis [32].
Lowering the levels of MSL2 available in the nucleus also
leads to binding of the DCC to a reduced set of sites [27,28].
MSL2-expression constructs with mutations in the 59 and/or
39 UTR that make them less sensitive to regulation by SXL
(SXB-1, NOPU), can be used to express different levels of
MSL2 protein in females (Figure 1B, [27]). As previously
noted [28], the subset of sites visible in these females matches
those visible in females carrying msl mutations .
The identiﬁcation and characterization of two speciﬁc
binding sites for the DCC within the roX1 and roX2 genes
provided support for the ‘‘recruitment and spreading’’ model
[31,33,34]. The roX1 and roX2 genes are part of the restricted
set of sites that appear in the msl-3
1 mutant [32]. When roX
genes were inserted into autosomes via P element trans-
formation, the DCC was recruited to the insertion site both in
wild-type and mutant backgrounds, suggesting that these
genes contain ‘‘entry sites’’ for the complex [31]. Detailed
studies led to the identiﬁcation of a 110 base pair (bp) DNA
binding element within male-speciﬁc DNAseI hypersensitive
sites in both roX1 and roX2 [35]. Importantly, the DCC could
occasionally be seen to spread from the ectopic roX loci to
neighboring autosomal chromatin [31]. The spreading was
characterized by DCC binding close to the insertion sites on
polytene chromosomes. Further studies revealed that the
spreading could be expanded by raising the levels of DCC
present in the cell or reducing the number of roX loci [36].
The ‘‘entry-site and spreading’’ model appeared attractive
because of its similarity to current views of how mammalian X
inactivation is achieved. However, the generality of the model
was challenged by more recent studies, which showed that
recruitment of the DCC is not a property of a small set of
entry sites, as many large X-derived fragments were able to
recruit the complex to ectopic autosomal sites [37,38].
Furthermore, characterization of a third DCC binding site
at polytene band 18D10 revealed only minimal spreading in
rare cases [37]. No spreading was observed from X to
autosome translocations, even when they contained a roX
gene [38]. In addition, when pieces of autosomes were
translocated to the X, the DCC did not bind to the
translocated chromatin, but stayed speciﬁc to X derived
chromatin [37,38]. Collectively, these results lead to the
proposition of an alternative model for the recruitment of
the DCC to the X not involving spreading, but rather
involving a large number of speciﬁc binding sites with
varying afﬁnities for the complex [38,39]. In this model, each
site of DCC binding on the X involves speciﬁc recognition
and only depends on the concentration of the complex
available. Studies of DCC binding in females expressing
varying levels of MSL2, discussed above, support the concept
of sites with different afﬁnities [28].
Clearly, evaluation and reﬁnement of current concepts for
DCC recruitment requires analysis of a larger number of DCC
binding sites. In this study we have used chromatin
immunoprecipitation (ChIP) to identify a number of new
DCC binding fragments (DBFs) from the X and characterized
them in vivo. Among them are sites that are bound by the
DCC even in msl mutant backgrounds (novel ‘‘chromatin
entry sites’’ by the old nomenclature). We show that the
identiﬁed fragments have different abilities to recruit the
DCC when inserted into autosomes. By varying complex
levels, we gained support for the existence of sites with
different afﬁnities for the complex on the X. Rare cases of
secondary binding sites close to high-afﬁnity inserts appear
not to be due to non-speciﬁc spreading of the complex along
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Synopsis
In fruit flies, just like in humans, the two sexes are distinguished by
different sex chromosomes. Females have two X chromosomes and
hence a double dose of all X-linked genes when compared to males,
which only have a single X chromosome. This different gene dosage
needs to be compensated for by adjusting transcription levels such
that male and female cells synthesize equal amounts of gene
products. In Drosophila melanogaster, dosage compensation occurs
by doubling the transcription of many genes on the single male X.
This chromosome-wide control is achieved by a male-specific
dosage compensation complex (DCC), which contains enzymes,
structural proteins, and non-coding RNA. How is the DCC able to
distinguish the X chromosome from the autosomes for selective
interaction? In the following article, the authors identify and
characterize several novel DNA sequences on the X chromosome
that can recruit the DCC. Their results suggest that the X
chromosome contains a large number of binding sites for the
DCC, which are made up of combinations of degenerate sequence
elements. These elements constitute binding sites with varying
affinities for the complex. Collectively, their abundance on the X
chromosome restricts the action of DCC to the X chromosomal
territory.the chromatin ﬁber, but rather to recognition of low-afﬁnity
binding sites nearby. In addition, we identiﬁed pairs of
sequence elements that are common between the new high-
afﬁnity DBFs and previously characterized sites, and found
that some of these are modestly enriched on the X.
Results
Identification of DCC Binding Fragments Using ChIP
To identify DNA fragments associated with the DCC, we
performed ChIP from mixed-sex Drosophila embryos using
anti-MSL1 antibodies. Because the DCC is not present in
female embryos, these are expected to contribute only
background-level signals in the ChIP. Labeled DNA recovered
from the ChIP experiments was hybridized to a commercial
membrane (previously available from Genome Systems)
containing 9,216 bacteriophage P1 clones [40,41] with an
average size of 85 kb, theoretically representing approxi-
mately six times genome coverage. Visual comparison of
MSL1 versus mock ChIP signals revealed several clones that
were enriched in the MSL1 ChIP (Figure 2A). Strikingly, all
clones mapped to the X chromosome.
With the aim of identifying strongly hybridizing restriction
fragments for cloning and further mapping, we prepared
bacteriophage DNA from each of the clones. The MSL1 ChIP
probes were used to identify strongly hybridizing restriction
fragments ranging from 1 to 8.5 kb within the P1 clones
(Figure 2B). In cases in which no single band could be
identiﬁed as the strongest site of hybridization, two bands
were selected. Hybridization with an MSL3 ChIP probe to the
digests produced a similar pattern, verifying the enrichment
of the DCC on these fragments (data not shown). The selected
restriction fragments were cloned and subjected to a third
round of hybridization. Quantiﬁcation of the MSL1 ChIP
signals compared to the mock signals allowed us to select a
single candidate fragment from each P1 clone. The 59 and 39
ends of the clones were sequenced to allow precise local-
ization of the fragments on the X chromosome and the
projected full-length sequences obtained from release 4 of
the Drosophila genomic sequence. The identiﬁed fragments,
named ‘‘DCC binding fragment’’ (DBF) 1–14, are listed in
Table 1 with associated accession numbers. All the fragments
contain genes or parts of genes (exons and introns) and some
contain intergenic regions. DBF14 overlaps with the pre-
viously identiﬁed high-afﬁnity DCC binding site at 18D [37]
and was not analyzed further in this study.
MSL1 Binding to Endogenous Loci of DCC Binding
Fragments
We ﬁrst wanted to explore if the DBFs identiﬁed using
ChIP were bound by the DCC in vivo, and speciﬁcally if they
could be part of the subset of sites seen in the msl-3
1 mutant.
The fact that one of the fragments, DBF14, had already been
shown to overlap with the DCC binding site at 18D was
encouraging [37]. In addition, when the cytological positions
of the DBFs were compared with the mapped positions of
high-afﬁnity sites [28], several were found to putatively
overlap with such sites (Table 1).
To investigate if the fragments indeed overlapped with
MSL1 binding on polytene chromosomes, we carried out
combined immunoﬂuorescence and ﬂuorescence in situ
hybridization (immuno-FISH) experiments using the anti-
MSL1 antibody and part of the DBF sequences as probes.
Initial experiments performed in the msl-3
1 background
Figure 1. The Drosophila X Chromosome Contains a Hierarchy of DCC Binding Sites
Polytene chromosomes from Drosophila larvae showing the DNA stained in blue and anti-MSL1 staining in red.
(A) The DCC binds in a defined pattern to the X chromosome in wild-type males (top panel). Mutations in mof, msl-3, and mle lead to partial or non-
functioning complexes (cartoons) binding to a subset of sites. Anti-MSL-1 staining of X chromosomes from females expressing MSL2 and homozygous
for the mof
1, msl-3
1, and mle
1 mutations are shown.
(B) The same hierarchy of sites can be seen in females expressing different concentrations of MSL2. The NOPU and SXB1–2 constructs give rise to
decreasing levels of MSL2 expression [27], and this leads to the recruitment of the DCC to decreasing numbers of sites on both X chromosomes. These
sites are the same as those found in the mutant backgrounds described in (A) [28]. Females homozygous for the NOPU construct (top panel) have a
DCC binding pattern quite similar to wild-type males, lacking only a few sites.
DOI: 10.1371/journal.pgen.0020005.g001
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Targeting Dosage Compensationrevealed that the FISH signals for ﬁve of the ten fragments
(DBF12, DBF11, DBF9, DBF6, and DBF5) did indeed overlap
with anti-MSL1 signals (Figure 3). The overlap of the signals
was conﬁrmed by confocal microscopy (data not shown). Two
of the DCC binding fragments, DBF12 and DBF11, are
located only 20 kb apart within the same gene. Confocal
analysis revealed that the FISH signal for DBF12 overlapped
almost completely with the MSL1 signal, whereas the signal
for DBF11 overlapped only minimally (data not shown). The
remainder of the identiﬁed fragments did not overlap with
signiﬁcant anti-MSL1 signal in the msl-3
1 background. We
therefore repeated the immuno-FISH in other genetic back-
grounds in which additional DCC binding sites are present on
the X (see Figure 1). We found that FISH signals for DBF1 and
DBF7 overlapped with MSL1 staining in the mof
1 background
and in females carrying one copy of the NOPU insert
(although the MSL1 signals are often weak) (Figure 3). The
endogenous DBF10 overlapped with MSL1 staining in females
carrying two copies of the NOPU insert, whereas DBF13 and
DBF3 only overlapped with DCC binding sites in wild-type
males (Figure 3). In summary, the results from the immuno-
FISH experiments (summarized in Table 1) indicated that the
Figure 2. Identification of New DCC Binding Fragments Using Chromatin IP
(A) Subsection of genomic P1 phage clone filter, showing 120 clones out of a total of 9,216, hybridized with MSL1 ChIP probe (upper panel), then
stripped and re-hybridized to the mock IP control (lower panel). Two examples of clones showing MSL1 enrichment chosen for further analysis are
indicated by red circles. Note that clones are always spotted in duplicate on the membrane.
(B) Southern blots of digested P1 clone DNA hybridized to MSL1 ChIP (left panel) or mock ChIP (right panel). Red boxes highlight the bands enriched in
the MSL1 ChIP chosen for cloning, known as DBF1–DBF14. Size in kilobases is indicated to the left of the figure. Lane order and restriction digests are as
follows: Lane 1, DBF1 (BglII); 2, DBF3 (XhoI); 3, DBF5 (XhoI); 4, DBF6 (ApaLI); 5, DBF7 (BamHI); 6, DBF9 (XhoI); 7, DBF10 (EcoRI); 8, DBF11 (ApaLI); 9, DBF12
(EcoRI); 10, DBF13 (EcoRI); 11, DBF14 (EcoRI); and 12, autosomal DNA control P1 clone (EcoRI). Note that clones DBF2, DBF4, and DBF8 (false positives)
have been omitted from this figure. P1 phage clone identifiers are listed in the Materials and Methods section.
DOI: 10.1371/journal.pgen.0020005.g002
Table 1. DCC Binding Fragments Identified by ChIP
Name Size in bp Accession Number Cytological Position
a Closest Mapped DCC
Binding Site in msl-3
1b
ImmunoFISH Analysis
c
DBF1 5,340 BK005736 2B14 2B mof
1
DBF3 3,027 BK005737 3A7 3A4–6 WT
DBF5 4,396 BK005738 5E5–6 5D6–8 msl-3
1
DBF6 2,441 BK005739 8F7 8F8–10 msl-3
1
DBF7 6,626 BK005740 10F2 10D3–6 mof
1/ NOPU
DBF9 7,646 BK005741 18D3 18D1–6 msl-3
1
DBF10 8,340 BK005742 2F1 2F1–5 NOPUx2
DBF11 4,090 BK005743 11B10 11B16-D msl-3
1
DBF12 5,163 BK005744 11B13 11B16-D msl-3
1
DBF13 4,314 BK005745 10B4 10B8–10 WT
DBF14 3,190 BK005746 18D11 18D11–13 nd
Fragments identified by ChIP were named DBF1–14. DBF2, DBF4, and DBF8 were excluded as false positives after Southern analysis. Accession numbers are from submissions to the Third Party Annotation Database within
GenBank.
aCytological positions from BLAST searches in FlyBase.
bClosest mapped binding site from [28].
cImmuno-FISH: genetic background with the lowest number of DCC binding sites visible on the X in which the endogenous FISH signal still overlaps with MSL1 staining. All DCC sites found in the msl-3
1 background are
also found in the mof
1 background. The NOPU MSL2 expression constructs leads to 60–120 DCC binding sites on the X in females including all the sites found in the mof
1 background.
mof
1representsmof
1/mof
1;þ;[w þHsp83MSL2]/þ;msl-3
1representsw/w;msl-3
1,[wþHsp83MSL2]/þ;ndindicatesnotdone;NOPUrepresentsfemalecarryingonecopyofthe[wþNOPU#2]insert;WTindicateswild-typemale.
DOI: 10.1371/journal.pgen.0020005.t001
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Targeting Dosage Compensationfragments identiﬁed by ChIP were all very close to or
coincident with in vivo DCC binding sites and hence good
candidates for DCC binding determinants. Furthermore, the
set of fragments contains representatives of different classes
of DCC binding determinants, as deﬁned by MSL1 binding in
different genetic backgrounds.
In Vivo Analysis of DCC Binding Fragments
It is possible that the DNA fragments found to be
associated with the DCC by ChIP do not represent recruit-
ment sites for the DCC, but rather represent the distribution
of active complex on the X chromosome. In order to
investigate if the new DBFs were able to recruit the DCC in
vivo, we employed the same assay as was used in the analysis
of the roX1, roX2, and 18D sites [31,37]. The ten DBFs were
cloned into the pCasper4 P-element vector for generation of
transgenic ﬂies. Preliminary analysis of the DBF sequences
had revealed that a number of them contained OPA repeats
[42]. To investigate a possible role for OPA repeats in DCC
binding in vivo, DBF12 was split to yield a 59 construct
containing the OPA sequences (DBF12-A) and a 39 construct
devoid of such repeats (DBF12-B). Due to its large size, DBF9
was also cloned in two halves, generating DBF9-A and DBF9-
B. For each construct, several different insertions of the P
element on the second and/or third chromosomes were
selected. The insertion sites were mapped by DNA FISH using
the mini-white gene as a probe (Figure 4). Recruitment of the
DCC to the inserts was analyzed by anti-MSL1 immunostain-
ing on polytene chromosomes. It had previously been shown
that the presence of MSL1 entails the presence of the whole
DCC [31]. For each DBF, we analyzed between three and ﬁve
different inserts in order to minimize bias from position
effects. For each insert in each genetic background, a total of
50–100 nuclei from two or three different individuals were
examined. It was immediately clear that the different DBF
insertions possessed different DCC recruitment abilities.
Variation could be observed in the signal intensity of the
anti-MSL1 staining compared to the signals on the X as well
as the number of nuclei in which the signal could be
observed. Typically, strong signals were observed in a high
percentage of nuclei, whereas weak signals could only be
observed in a subset of nuclei. In addition, different
insertions of the same DBF showed different recruitment
abilities indicating that they were subject to position effects.
Recruitment of the DCC to autosomal insertions of DBF
constructs was ﬁrst investigated in wild-type males. For nine
out of the eleven DBFs, anti-MSL1 signals could be detected
for at least one insert. DBF5, DBF6, DBF7, DBF12-B, and
DBF9-B had strong recruitment ability at all insertion sites,
whereas DBF1, DBF9-A, DBF11, and DBF13 had variable
recruitment ability (Table 2). These initial results indicated
Figure 3. The Endogenous Loci of the DCC Binding Fragments Overlap with MSL1 In Vivo
Immuno-FISH experiments using the identified DBFs as probes (FISH signals in green) and staining with anti-MSL1 antibodies to visualize DCC binding
(in red). Each panel consists of images of the FISH signal (top), the anti-MSL1 signal (middle), and the merge (bottom). The FISH signals from DBF9,
DBF6, DBF5, and DBF12 overlap with the anti-MSL1 signals in the msl-3
1 mutant background (w/w; msl-3
1, [wþHsp83 MSL2]). DBF11 overlaps partially
with MSL1 staining in this background. DBF1 and DBF7 overlap with weak anti-MSL signals in the mof
1 mutant background (mof
1/mof
1;þ;[ w þHsp83
MSL2]/þ). FISH signals from the endogenous loci of DBF3, DBF10, and DBF13 do not overlap with MSL1 staining in either the msl-3
1or mof
1 background.
However, DBF10 does overlap with MSL1 staining in females carrying two copies of the NOPU insert (2 3 NOPU, Figure1), whereas DBF3 and DBF13
overlap with MSL staining in wild-type males (WT).
DOI: 10.1371/journal.pgen.0020005.g003
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indeed reﬂects an in vivo association of the DCC with most of
these sequences. No anti-MSL1 signal could be detected at
any inserts of DBF3 and DBF10. These fragments are also
among the weakest DCC interaction sites in their native X
chromosomal context (see Figure 3). Inserts of DBF12-A were
also unable to recruit the DCC, excluding a connection
between OPA repeats and DCC binding. The variability in the
recruitment of the DCC indicates that the identiﬁed frag-
ments have different afﬁnities for the complex.
Recruitment of the DCC at Varying Complex
Concentrations
Investigation of differences in afﬁnity between DBFs
requires that the levels of intact complex be varied. As
discussed in the introduction, expression of varying MSL2
levels in females leads to corresponding levels of intact DCC,
which associates with both X chromosomes (Figure 1). We
ﬁrst investigated the ability of the ten DBFs to recruit the
DCC in females carrying one copy of the SXB1-2D MSL2-
expression construct. Due to lower than wild-type MSL2
levels only 30–60 DCC binding sites are visible on the X
chromosomes of these females (Figure 1, [27]). Those frag-
ments that gave rise to the most robust binding in wild-type
males were also able to recruit the DCC in this background,
albeit less efﬁciently (Figure 5). Insertions of DBF12, DBF9-B,
and DBF5 showed intermediate anti-MSL1 signals, whereas
insertions of DBF6, DBF7, and DBF1 showed only very weak
and occasional signals. None of the other fragments seemed
to recruit the DCC at this concentration of complex (Table 2).
Next we analyzed recruitment ability in females carrying one
copy of the NOPU MSL2 construct. In these females, the DCC
binds to between 60–120 sites on the X, reﬂecting higher
levels of MSL2 expression (Figure 1,[27]). Under these
conditions the recruitment potential of DBF6, DBF7, and
DBF1 was enhanced (Table 2). In addition, one insert of both
DBF9-A and DBF11 showed weak anti-MSL1 signals (Figure
5). These results provide further evidence that the DBFs we
isolated have different afﬁnities for the DCC in vivo.
None of the autosomal inserts of DBF3 or DBF10 were able
to recruit the DCC in wild-type males. In addition, some
inserts of DBFs with moderate recruitment ability (i.e., DBF11
and DBF13) were also negative for MSL1 binding in vivo
(Table 2). We wanted to investigate if increasing the
concentration of the DCC in the nucleus would allow DCC
binding to such sites. Over-expressing MSL1 and MSL2 in
male ﬂies raises the levels of the DCC leading to increased
binding to the X, which disrupts the morphology of this
chromosome [43]. In addition, the association of the DCC
with many autosomal sites becomes visible [28]. We found
that DBF inserts with weak recruitment potential showed
more robust binding of the DCC under conditions of MSL1
and MSL2 over-expression (Figure 6 and Table 2). In
addition, some inserts that were not bound in wild-type
Figure 4. Recruitment of the DCC to DBF Insertions in Wild-Type Males
Polytene chromosomes with FISH signals in green and anti-MSL1 signals in red showing examples of DBF insertions recruiting the DCC in wild-type
males. The cytological position of DBF inserts was estimated from FISH experiments (upper image in each panel). Recruitment of the DCC was
demonstrated with immunoflourescence using anti-MSL1 antibodies (lower image in each panel). Examples from all DBF inserts that showed
recruitment in wild-type males are shown. A summary of the complete analysis can be found in Table 2.
DOI: 10.1371/journal.pgen.0020005.g004
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and MSL2 were over-expressed (Figure 6, Table 2). This
suggests that DBF3 has very low afﬁnity for the complex,
whereas DBF10 and DBF12-A have no detectable afﬁnity in
this assay. However, we cannot exclude that critical DCC
binding determinants were lost during the selection and
subcloning of these fragments from the original P1 clones.
Recruitment of Partial Complexes
To investigate the ability of the DBFs to recruit partial and
non-functional DCC complexes, we looked for anti-MSL1
staining in the msl mutant backgrounds. The analysis was
done in females expressing MSL2 and homozygous for the
msl-3
1 or mof
1 mutations. All the inserts that showed recruit-
ment in wild-type males were tested for recruitment of
complexes lacking MSL3. From the initial immuno-FISH
analysis, we knew that at least four of the endogenous DBF
loci overlap with DCC binding sites in this background.
Indeed, DBF12-B, DBF9-B, and DBF6 were able to consis-
tently recruit partial DCCs (Figure 7) and, therefore, qualify
as novel ‘‘chromatin entry sites’’ in the old terminology. One
insert of DBF5 also shows weak anti-MSL1 signals in the msl-
3
1 background, so may be considered a fourth new entry site.
The mof
1 mutation leads to the formation of a DCC that lacks
the histone acetyltransferase activity. In terms of DCC
recruitment to the X, the mof
1 mutation is less damaging
than the msl-3
1 mutation (Figure 1). DBF insertions that
recruit the DCC in the msl-3
1 background would therefore
Table 2. Summary of In Vivo Analysis of DCC Binding Fragments
DCC Binding
Fragment
Insert
a DCC Recruitment
b
msl-3
1 mof
1 SXB1–2 NOPU WT Male MSL1, MSL2
DBF12-B 85A þ nd  /þ þ þþþþ þþþþ
99EF þþ nd þ þþ þþþþ nd
23A þ nd þ þþ þþþþ þþþþ
DBF9-B 96C þþ nd þþ þþ þþþþ S þþþþ S
98F þ nd  /þ þ þþþ nd
35EF nd      /þ þþþ nd
DBF6 100A þ þ þ þ þþþ þþþþ
63C  /þ þ   þ þþþ þþþþ
79E   nd nd nd þ nd
DBF5 95C  /þ nd þ þþ þþþþ nd
91F    /þ   þ þþþþ S þþþþ S
45E  þ nd þþ þþþ nd
DBF7 88E  þ   /þ þþ þþþþ Sn d
45D    /þ  /þ þþ þþþ nd
93B   nd nd þþ þþþþ nd
DBF1 26A nd  /þ þ þþ þþþ nd
28C nd nd nd nd  þ
61CD nd nd nd nd   
DBF9-A 96D      /þ þ þþþþ nd
82DE    nd   þ þþþ
92A nd nd nd nd   nd
DBF13 83A    nd   þþþ nd
67D    nd  þ þ nd
85D nd nd nd nd   nd
DBF11 73C nd      /þ þþþ þþþþ
85D nd nd nd    /þþ þ
62A nd nd nd nd    /þ
DBF3 96B nd nd nd nd  þ
61F nd nd nd nd  þ
88B nd nd nd nd   
62B nd nd nd nd   
DBF10 95C nd nd nd nd   
73D nd nd nd nd   
21C nd nd nd nd   
93F nd nd nd nd   
DBF12-A 50B nd nd nd nd   
91F nd nd nd nd   
77D nd nd nd nd   
96F nd nd nd nd   
aLocation of inserts estimated from FISH experiments.
bVarying degrees of DCC recruitment as assayed by anti-MSL1 staining on polytene chromosomes indicated as follows: (undetectable signal); /þ(very weak signal in less than 25% of nuclei);þ(weak signal in 25%–50%
of nuclei); þþ (moderate signal in 50%–75% of nuclei); þþþ (strong signal in more than 75% of nuclei); and þþþþ (strong signal in 100% of nuclei); nd indicates not done; S indicates minimal spreading.
Genetic backgrounds: mof
1 represents mof
1/mof
1;þ;[ w þHsp83 MSL2]/þ; msl-3
1 represents w/w; msl-3
1, [wþHsp83 MSL2]/þ; MSL1, MSL2 represents male carrying one copy of each of the [wþHsp83 MSL1] and [wþHsp83
MSL2] inserts; NOPU represents female carrying one copy of the [wþ NOPU #2] insert; SXB1–2 represents female carrying one copy of the [wþ SXB1–2 D] insert.
DOI: 10.1371/journal.pgen.0020005.t002
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Targeting Dosage Compensationalso be expected to recruit the DCC in a mof
1 mutant
background, and this was demonstrated for a subset of inserts
(Table 2). In addition, two inserts of DBF7 were able to
recruit the DCC weakly in the mof
1 background (Figure 7).
The binding fragments with low afﬁnity for the DCC were not
able to recruit partial or mutant complexes (Table 2). We
conclude that the afﬁnity of binding sites as judged from
recruitment at different DCC levels correlates with their
ability to attract partial or non-functional complexes.
Additional Binding of the DCC Close to Ectopic High-
Affinity Sites
During our analysis of the DBFs in wild-type males, we
observed rare cases of additional DCC binding close to inserts
of the high-afﬁnity fragments DBF12, DBF5, and DBF7 (Table
2 and Figure 5). This is reminiscent of the minimal ‘‘spread-
ing’’ of the DCC observed from the roX1 and roX2 transgenes
[31,36] and the more recently described 18D site [37]. Because
more extensive spreading from roX transgenes (both in terms
of number of additional binding sites and distance from the
insertion) could be achieved by raising the levels of DCC
[28,36], we investigated if we could induce spreading from
other high-afﬁnity sites by over-expressing MSL1 and MSL2.
Even at increased DCC levels, we could not detect additional
bands of DCC binding close to any inserts other than those
already seen to support such additional binding events. For
the three inserts that did show a secondary band in wild-type
nuclei, this band could be detected more often if MSL1 and
MSL2 were over-expressed (data not shown). However, the
secondary bands associated with the DBF9-B-96C and DBF5-
91F inserts could also be observed in controls over-expressing
MSL1 and MSL2 in which the inserts were not present (Figure
8). Consequently, these additional bands belong to those
autosomal sequences of lowest afﬁnity that attract complex
only if DCC concentrations are experimentally increased
beyond physiological levels.
Identification of Common Sequence Elements in DCC
Binding Fragments
This study has lead to the identiﬁcation of a number of new
high-afﬁnity binding fragments for the DCC. We explored
whether it was possible to identify common elements between
these and previously characterized fragments that may
contribute to deﬁning DCC binding sites. We considered
DBF12-B, DBF9-B, DBF6, DBF5, and DBF7 to contain high-
afﬁnity sites as they produced consistent DCC recruitment in
wild-type males as well as in msl-3
1 and/or mof
1 mutants. In
addition, we included the full-length roX1 and roX2 sequences
[44] and the 8.8 kb fragment of 18D [37]. DBF10 and two large
autosomal regions from 2L and 3R represent fragments with
no afﬁnity for the DCC (no recruitment of the DCC on
polytene chromosomes) and thus provided control sequences.
Initial analysis suggested that there were no simple nucleotide
sequences or ‘‘words’’ (6–10 bp) in common between all the
high-afﬁnity fragments that were also absent from the control
fragments. It is, however, conceivable that the DCC binding
sites consist of combinations or clusters of different words. In
Figure 5. Several DCC Binding Fragments Can Recruit the Complex
When MSL2 Levels Are Limiting
ExamplesofDCCrecruitmenttoDBFinsertsinfemalescarryingonecopyof
theSXB1–2or NOPUMSL2expressionconstructs(seeFigure1).Anti-MSL1
staining is shown in red and DNA staining in blue. Arrows indicate the
position of the inserts and X indicates the X chromosome. Inserts DBF12-
99EF (A), DBF12-85A (B), DBF9-96C (C), DBF6-100A (E), and DBF5-95C (G)
recruittheDCCatlowerlevelsofMSL2intheSXB1–2background,whereas
inserts DBF9B-98F (D), DBF6-63C (F), DBF5-91F (H), DBF7-88E (I), DBF7-93B
(J), DBF1-26A (K), and DBF9A-96D (L) recruit the complex in the NOPU
background. For a summary of the complete results, see Table 2.
DOI: 10.1371/journal.pgen.0020005.g005
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Targeting Dosage Compensationorder to search for such combinations, we limited the search
to words that were present in the roX1 or roX2D H S
fragments [33,35] as these are the best-studied high-afﬁnity
sites. Using these words, we identiﬁed a set of ‘‘elements’’
present in at least six out of the eight candidate fragments
that consist of families of 6–8 bp words related to each other
by a deﬁned allowance for mismatches (see Materials and
Methods). None of these elements were absent in the control
sequences.
In order to investigate possible clustering, we looked for
pairs of elements found within a 5–200 bp window. We
identiﬁed a large number of pairs present in at least six out of
eight of the high-afﬁnity fragments and absent in controls.
Many of the pairs were very similar or overlapping, and by
merging related pairs, we could generate a list of 61 pairs of
elements with two or fewer mismatches between the
individual words of each element. All of these pairs were
absent in the control sequences and present in a larger
number of high-afﬁnity fragments (seven or eight out of
eight) than the individual component pairs (a list of all 61
element pairs is available on request).
It would be expected that any element or combination of
elements (such as a pair) involved in dosage compensation
should be over-represented on the X chromosome compared
to other chromosomes. We therefore individually compared
the frequency of occurrence of each of the 61 element pairs
on the X to the frequency on the ﬁve other chromosome
arms. We found that 24 of the pairs were modestly, but
signiﬁcantly, enriched on the X compared to other chromo-
somes. Table S1 contains a list of the pairs with signiﬁcant
enrichment on the X, grouped together according to
sequence similarities. For each pair, we also calculated the
percentage of occurrence on the X out of total genomic
occurrences. Compared to the percentage expected from a
random distribution, all pairs occurred more often on the X
than expected (Table S1). The X chromosome enrichment of
most of the pairs may be explained by the presence of GAGA-
related sequences in one of the elements. It has previously
been shown that GA dinucleotide repeats are over-repre-
sented on the X [45,46]. It is interesting to note, however, that
most of the pairs are found at appreciably higher frequency
in the high-afﬁnity fragments compared to the moderate- and
low-afﬁnity fragments DBF1, DBF9-A, DBF11, DBF13, and
DBF3 (Table S1). Our results suggest that it is possible to
identify pairs of short elements in common between most of
the high afﬁnity fragments, which are also over-represented
on the X chromosome. However, the localization of these
pairs is not exclusive to the X and therefore not sufﬁcient to
explain the X-speciﬁc localization of the DCC.
Discussion
DCC Binding Sites of Different Affinities
Using a ChIP strategy, we have identiﬁed several new DCC
binding fragments and demonstrated that they possess a wide
range of potential to recruit the DCC. Because the majority of
the isolated candidate fragments co-map with endogenous
DCC binding sites at the resolution afforded by staining of
polytene chromosomes, we believe our ChIP selection
procedure was appropriate. By tuning DCC levels in vivo,
we came to conclude that the difference in recruitment
ability is due to different afﬁnity of the DCC for these
fragments. At limiting concentrations of complex, only the
sites of highest afﬁnity are occupied. Conversely, at non-
physiologically high concentrations of DCC, even ‘‘cryptic’’
binding sites on autosomes are recognized by the complex.
This suggests, in concordance with previous observations [28],
that selective interaction of the DCC with the X chromosome
is a function of tightly controlled levels of complex
Figure 6. Increasing the Levels of the DCC Increases Recruitment to Low-Affinity Binding Fragments
Polytene chromosomes showing FISH signals (top panels, green) and anti-MSL1 staining (red) in the genetic backgrounds indicated. Arrows indicate the
position of the inserts and arrowheads indicate autosomal sites of DCC binding in the MSL1 and MSL2 over-expression background. Recruitment of the
DCC to the DBF11-85D insert is enhanced when the levels of DCC are increased by over-expression of MSL1 and MSL2 compared to wild-type males.
The DBF3-96B insert does not recruit the DCC in wild-type males, but recruitment can be seen when MSL1 and MSL2 are over-expressed.
DOI: 10.1371/journal.pgen.0020005.g006
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Targeting Dosage Compensationcomponents that are adjusted to assure interaction with
binding sites of varying afﬁnity clustered on the X, but
insufﬁcient to occupy cryptic sequences on autosomes. Our
data are also in broad agreement with recent observations
from Oh et al. [37] and Fagegaltier and Baker [38], who found
that numerous sites on the X chromosomes contain DCC
binding determinants. We now show that these determinants
are not all equal, but represent a diverse set of DCC targets
that differ by a wide range of afﬁnities for the complex, as
expected from a sequence determinant that became gradually
enriched on the X chromosome during evolution.
The use of the term ‘‘chromatin entry sites’’ for the subset
of DCC binding sites that are still occupied by partial
complexes in the absence of MSL3 [31], implied that these
sites were somehow qualitatively and perhaps functionally
distinct from the remaining sites that only attract the intact
complex. Although it is possible that not all DCC binding sites
are functionally equivalent, our characterization of several
new examples of both types of DCC binding sites rather
supports the ‘‘afﬁnities model’’ [28,38]. According to this
model, ‘‘chromatin entry sites’’ are not qualitatively different
from other sites, but only represent those sites with the
highest afﬁnity for the complex. A prediction from this model
that is further substantiated by our results is that non-
functional complexes that lack MSL3 or the acetyltransferase
activity of MOF have lower afﬁnity for target sites. Only those
determinants with highest afﬁnity for the DCC are able to
recruit partial complexes in the absence of MSL3. Sites with
slightly lower afﬁnity are still able to recruit the complex in
the mof
1 mutant. Because the interaction of the DCC with the
X chromosome is thought to be largely mediated by MSL1
and MSL2 [47], it remains to be explored whether MSL3 and
the acetylase activity of MOF affect the active concentration
of MSL1 and MSL2 or lead instead to the adoption of a high-
afﬁnity conformation of the complex. Conversely, it remains
to be seen if over-expression of MSL1 and MSL2 in the msl-3
1
and mof
1 mutants would allow partial complexes to bind
additional sites. In this respect it is intriguing that the
mutation of both roX RNAs, which is presumed to lead to
incomplete and non-functional complexes, can be partially
rescued by the over-expression of MSL1 and MSL2 [30,43].
Distribution of the DCC
During our analysis of DCC recruitment to high-afﬁnity
sites inserted into autosomes of wild-type males, we observed
an additional band of DCC binding close to the insertion site
in three independent cases (one insert each of DBF9, DBF5,
and DBF7). Such minimal and rare ‘‘spreading’’ has pre-
viously been observed for ectopic insertions of the 18D high-
afﬁnity site [37] and from roX transgenes in the wild-type
male background [36]. Our study now reveals that these
additional DCC binding sites are not a result of random
spreading, but are most likely due to interaction of the DCC
with one of the low-afﬁnity sites on autosomes, which
happened to reside close to the insertion site (Figure 8).
These sites are usually only observed when the DCC
concentrations are globally increased by over-expression of
MSL1 and MSL2 [28]. Accordingly, we suggest that the
autosomal insertion of a high-afﬁnity DCC binding site leads
to a local rise in complex concentration, which allows these
low-afﬁnity sites to be recognized by the DCC even in wild-
type males. However, additional requirements must clearly be
met to allow low-afﬁnity sites to proﬁt from local increases in
complex concentration, as not all ectopic high-afﬁnity sites
support the phenomenon (I. K. Dahlsveen, unpublished data).
Permissive conditions may include active transcription or the
presence of speciﬁc epigenetic marks.
Figure 7. High-Affinity DCC Binding Fragments Recruit Partial and
Inactive Complexes in msl-3
1 and mof
1 Mutants
Examples of DCC recruitment to DBF inserts in females expressing MSL2
and carrying mutations in msl-3
1 (w/w; msl-3
1, [wþ Hsp83 MSL2]/þ)o r
mof
1 (mof
1/mof
1;þ;[ w þHsp83 MSL2]/þ). Anti-MSL1 staining is shown in
red and DNA staining in blue. Arrows indicate the position of the inserts
and X indicates the X chromosome. Inserts DBF12-B-99EF (A), DBF12-B-
85A (B), DBF9-B-96C (C), DBF9B-98F (D), DBF6-100A (E), and DBF5-95C (G)
recruit partial complexes in the msl-3
1 mutant. Inserts DBF6-63C (F),
DBF5-91F (H), and DBF7-88E (I) recruit inactive complexes in the mof
1
mutant background.
DOI: 10.1371/journal.pgen.0020005.g007
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Targeting Dosage CompensationWe envision that the clustering of DCC binding determi-
nants of high and intermediate afﬁnity on the X chromosome
(combined with the transcription of the roX RNAs) elevates
the concentration of the DCC within the X chromosomal
territory and ensures the occupancy of lower-afﬁnity sites in
a context-dependent manner. This may explain the observa-
tion that autosomally derived transgenes often acquire
dosage compensation. The transgenes may contain cryptic
DCC binding determinants and may thus acquire binding if
placed in the context of the X chromosomal territory.
Conversely, an X chromosomal fragment that harbors only
low-afﬁnity sites may not be recognized if translocated to an
autosomal context, and our fragment DBF3 may be an
example for such a scenario. The presence of a large number
of low-afﬁnity sites may also contribute signiﬁcantly to
restricting the binding of the DCC to the X chromosome.
The term ‘‘spreading’’ has been used to describe the
appearance of additional bands of DCC binding around
autosomal insertions of roX cDNAs or fragments derived
thereof [31,33]. However, extensive, long-range spreading
from roX transgenes, which leads to the appearance of many
ectopic DCC bands at greater distances from the insertion
sites, only occurs under unusual conditions and depends on
the transcription of the roX RNA rather than the DCC
binding sites on DNA [36,48]. Long-range spreading of the
complex also does not occur into autosomal chromatin
translocated to the X chromosome [37,38]. We suggest that
large translocations maintain their original chromosomal
context (DCC enriched or not), and therefore no redistrib-
ution of DCC over the new chromosomal junction is
observable at the resolution of the polytene chromosomes.
Importantly, our study does not address the higher-resolution
distribution of the DCC within a chromosomal band. It is
possible that such a band contains many individual binding
sites, also of varying afﬁnity. At this resolution, the term
‘‘spreading’’ may characterize the local diffusion of the DCC
from high- to low-afﬁnity sites. Our study does not exclude
this type of spreading, or indeed any other kind of complex
distribution within a chromosomal band. High-resolution
ChIP analyses will be necessary to resolve the detailed nature
of DCC distribution.
Defining DCC Binding Sites
Previously, only three high-afﬁnity binding sites for DCC
were known [35,37]. Our study identiﬁed nine more frag-
ments, which encouraged investigation of common features
within a larger pool. Interestingly, we ﬁnd that all new DBFs
map to gene-rich regions and either overlap with or lie close
to essential genes. Three high-afﬁnity fragments (DBF12,
DBF9, and DBF6) reside entirely within genes. It is possible
that speciﬁc recruitment sites, such as those inferred to reside
within our DBFs, have been enriched in and around genes
that require dosage compensation during evolution [8], and
consequently, high-afﬁnity sites may represent loci that are
particularly dosage sensitive. Previous experiments indicated
that the DCC tends to bind to the coding regions of genes
[49], and it was suggested that this was linked to transcrip-
Figure 8. Minimal Spreading from High-Affinity Sites to Low-Affinity
Autosomal Sites
Examples of two inserts, DBF9-96C (A–C) and DBF5-91F (D–F), that cause
occasional spreading of the DCC to one additional band next to the
insertion site in wild-type males (A and D). When complex levels are
increased by over-expression of MSL1 and MSL2, the secondary DCC
binding sites appear as part of the set of autosomal binding sites for the
complex (B and E) and are present even in the absence of the DBF insert
(C and F). Anti-MSL1 staining is shown in red and DNA staining in blue.
Small inserts in (A) and (E) show the FISH signals (green) corresponding
to the P element insertion. Arrows indicate the position of the inserts and
arrowheads indicate autosomal sites of DCC binding.
DOI: 10.1371/journal.pgen.0020005.g008
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Targeting Dosage Compensationtional activity [50]. Although recent observations suggest that
transcriptional activity alone is not sufﬁcient to attract DCC
binding [51], it is possible that transcription inﬂuences DCC
recruitment to speciﬁc sites. For example, high-afﬁnity sites,
which in our assays show consistent and strong recruitment
of the DCC at many chromosomal positions, may not be
inﬂuenced by transcription. However, sites with lower afﬁnity
and variable recruitment ability may proﬁt from transcrip-
tional activity. Developmental differences in transcriptional
activity may therefore also explain the lack of DCC recruit-
ment in salivary glands to fragments isolated by ChIP from
embryos.
We have attempted to identify common sequence elements
within previously characterized and new high-afﬁnity DCC
binding fragments and have uncovered a number of short
sequence elements, whose clustering in combinations could
contribute to DCC recruitment. Clearly, the importance of
these elements remains to be tested experimentally. Previous
analysis of the roX DCC binding sites identiﬁed a 110 bp
sequence containing several blocks of conservation between
roX1 and roX2 [35]. DCC binding was affected by mutation in
several of the conserved blocks, indicating that DCC binding
sites may be made up of combinations of shorter elements.
We have started to look for such combinations by deﬁning
pairs of elements found within a 200 bp window in the high-
afﬁnity DCC binding fragments. Those pairs that are
signiﬁcantly enriched on the X chromosome compared to
other chromosomes are listed in Table S1. Importantly, these
X-enriched pairs often occur in multiple copies in the high-
afﬁnity fragments (not shown) and at higher frequencies
compared to the lower-afﬁnity fragments DBF9-A, DBF1,
DBF11, DBF13, and DBF3 (Table S1). Nonetheless, there is no
obvious correlation between the location of individual pairs
on the X and any speciﬁc features such as predicted genes.
We hypothesize that the elements that deﬁne these pairs (and
other such elements that may have escaped our attention)
correspond to building blocks of DCC binding sites. Accord-
ingly, a DCC binding site of given afﬁnity for the complex
would not be determined by a unique DNA sequence, but by
clustering of variable combinations of short, degenerate
sequence motifs, as previously suggested [8]. Individual low-
afﬁnity binding sites may not be unique to the X, but their
clustering on the X may contribute to high-afﬁnity binding
[52]. We already have indications that the DCC binds to
several sites in close proximity. The two parts of DBF9, DBF9-
A and DBF9-B, are both able to recruit the DCC, albeit with
different afﬁnity. The analysis of the 18D high-afﬁnity
fragment also suggested that multiple elements over 8.8 kb
contribute to the binding of the complex [37].
In Table S1, we have ordered the pairs according to
sequence similarity. Interestingly, a large family of elements
contain GAGA-related motifs. Mutation of GAGA or CTCT
motifs in the 110 bp roX1/roX2 consensus severely affected
DCC recruitment to that sequence, indicating that GAGA
motifs are involved in DCC binding [35]. The fact that we ﬁnd
these elements enriched in several independently identiﬁed
high-afﬁnity fragments demonstrates the appropriateness of
our algorithms. Besides elements with a clear relationship to
GAGA motifs, we also noticed several other element families
deﬁned by sequence similarity (separated by broad horizontal
bars in Table S1). In order to visualize the element families,
the related words may be aligned such that sequence logos
representing degenerate motifs can be derived using the
WebLogo software (http://weblogo.cbr.nrc.ca). Pairs of repre-
sentative motifs are shown in Figure 9, but the logos are less
constrained than the original pairs of elements and therefore
do not only represent pairs speciﬁcally enriched on the X.
However, we consider it possible that some of these
degenerate motifs may contribute to DCC binding sites.
Evaluation of the contributions of these novel motifs to the
targeting of the complex will require increased resolution
analysis and systematic evaluation of candidate sequences in
the in vivo recruitment assay.
DCC–DNA Interactions
Our study suggests that high-afﬁnity DCC binding sites are
composed of variable combinations of clustered, degenerate
sequence motifs. The degeneracy of the sequence motifs
indicates that many individual elements may have low
afﬁnity. Therefore, the interaction of the DCC with each
individual site should be in dynamic equilibrium. However,
we recently observed by photobleaching techniques that the
DCC components most likely involved in chromatin binding,
MSL2 and MSL1, interact with the X chromosomal territory
in cultured cells in an unusually stable manner [53], which is
not compatible with binding equilibria involving off-rates
that commonly characterize protein–DNA interactions. Sev-
eral hypotheses can be formulated, whose evaluation may
lead to resolution of this apparent contradiction. First,
Figure 9. DNA Sequence Logos of Representative Motifs Putatively
Involved in DCC Binding
Logos (generated using the WebLogo software) represent degenerate
motifs based on related pairs of elements from Table S1. The logos were
generated by aligning all the words of related elements from specific
pairs: (A) pairs 5, 6, 7, 8, 9, and 10; (B) pairs 11, 12, 13, and 14; (C) pairs 17,
18, 19, and 20; (D) 21, 22, and 23; (E) pairs 15 and 16; and (F) pairs 1, 2,
and 3. Pairs 4 and 24 were not included. Motifs Ia–Ie all contain GAGA-
related sequences. Motifs IIa and IIb as well as IIIa–IIIc are also related to
each other.
DOI: 10.1371/journal.pgen.0020005.g009
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Targeting Dosage Compensationformation of higher-order structures involving many DCC
components engaged in numerous simultaneous DNA inter-
actions may lead to a trapping of the DCC within the X
chromosome territory. Second, an initial sequence-directed
targeting event may be followed by a stabilization of the
interaction through positive reinforcement involving addi-
tional principles, such as epigenetic marks or a topological
linkage (see [53] for discussion). Finally, we consider that the
arrangement of the interphase genome in polytene chromo-
somes may differ in a relevant aspect from the more compact
chromosomal territories of diploid cultured cells. Ultimately,
the identiﬁcation of the DNA-binding domains of DCC
components and analysis of their mode of DNA interaction
will be required to solve the targeting issue.
Materials and Methods
P1 clones and cloning of DBFs. Bacteriophage P1 clone (sources of
DBF clones) identiﬁers are as follows: DBF1 (DS00954); DBF2
(DS05757); DBF3 (DS02577); DBF4 (DS04038); DBF5 (DS00375); DBF6
(DS05338);DBF7(DS00951);DBF8(DS06397);DBF9(DS09077);DBF10
(DS08342); DBF11 (DS08372); DBF12 (DS04200); DBF13 (DS01141);
DBF14(DS04283).CloneswereobtainedfromtheBerkeleyDrosophila
Genome Project (http://www.fruitﬂy.org) and maintained on LB agar
containing 25 lg/ml kanamycin. During early to mid log-phase growth
inliquidculture,P1phagereplicationwasinducedbyadditionof1mM
IPTGandcellsharvestedafterafurther2–3h.DNAwaspreparedusing
Qiagen Maxiprep kits (QIAGEN GmbH, Hilden, Germany). The
genomic location of two clones had been previously mapped by in
situ hybridization [40], seven had been partially sequenced [54], and
short sequences were generated in our lab for the remaining clones.
For cloning of highly enriched fragments from the ChIP, P1 phage
DNA was digested with restriction enzymes as detailed in Figure 2
and the DNA ligated with pBluescript SK (Stratagene, La Jolla,
California, United States) digested with EcoRI (DBF10, DBF12,
DBF13, and DBF14), XhoI (DBF3, DBF5. and DBF9) or BamHI
(DBF7). In three cases, insert DNA was ﬁlled-in with Klenow
polymerase prior to cloning into pBluescript SK digested with
EcoRV (DBF1, DBF6, and DBF11). All clones were maintained in
Escherichia coli XL-1 Blue (Stratagene).
DBF P-element clones were prepared by releasing inserts from
DBF pBluescript subclones (using original cloning sites or ﬂanking
sites in the polylinker) and inserting into pCaSpeR4. In addition,
DBF9 and DBF12 were each divided into two smaller sub-fragments
and cloned into pCaSpeR4; DBF9-A (5.5 kb XhoI/BamHI fragment),
DBF9-B (3.9 kb Asp718I/XhoI fragment), DBF12-A (3.0 kb EcoRI/
Asp718I fragment), DBF12-B (2.6 kb XhoI/EcoRI fragment).
Chromatin immunoprecipitation. ChIPs were performed on
chromatin prepared from 12- to 14-h-old mixed-sex embryos as
described previously, including puriﬁcation over a CsCl gradient [33].
Embryos were ﬁxed in 4% formaldehyde at 18 8C for 15 min. Afﬁnity-
puriﬁed anti-MSL1 antibody (2 ll/ immunoprecipitation [IP]) was a
gift from M. Kuroda. Following IP and reversal of cross-links,
recovered DNA was resuspended in a ﬁnal volume of 22 llo fH 2O.
Seven microliters of this DNA was incubated with Pfu polymerase,
ligated to linker, and subjected to linker-mediated PCR prior to
random priming for use as a probe in Southern hybridization.
Southern transfer and hybridization. Approximately 1 lgo f
bacteriophage P1 DNA per lane was digested with restriction enzyme
and loaded on 0.8% agarose gels. Electrophoresis and Southern
transfer was performed as described [10]. A total of 100 ng of LM-
PCR ampliﬁed DNA from MSL1 or mock ChIP was labeled using the
Megaprime labeling system (Amersham Biosciences, Little Chalfont,
United Kingdom), puriﬁed over G-50 columns (Roche, Mannheim,
Germany) and equal amounts of speciﬁc or mock IP, as determined
by scintillation counting, used as a probe in Southern hybridization.
Southern hybridization was performed as described [55]. Signals were
quantitated using a Fuji FLA-3000 phospho-imager (Tokyo, Japan).
Due to the presence of repetitive elements in some clones,
subtracting mock IP signals from the MSL1 IP signal was used as an
indicator of a clone’s binding to MSL1.
Drosophila genetics. Flies were raised on standard cornmeal-agar-
yeast medium (including 0.25% Nipagin) at 18 8Co r2 58C. All the
stocks carrying MSL mutations and MSL2 expression constructs were
kindly provided by M. Kuroda and R. Kelley. Alleles used in this study
were:msl-3
1,mof
1,msl-2
1,mof
þt6.8,msl-2
SXB1–2,msl-2
NOPU,msl-1
Hsp83.PC,and
msl-2
Hsp83.PK. To generate transgenic ﬂies carrying DBF insertions,
fragments were cloned into the pP[CaSpeR-4] vector and the resulting
P elements injected into w
1118 or y
1w
1118 stocks that also served as
the wild-type background. Several different insertions on the
second and third chromosomes were generated for each construct.
In order to analyze the DBF insertions in females expressing
different levels of MSL2, homozygous inserts on the second or third
chromosome(orheterozygousinsertonthethird/TM6)werecrossedto
w; msl-2
1 cn; [wþ SXB1-2D] or w; [wþ NOPU #2] and female larvae
selected for analysis. To analyze insertions in males over-expressing
MSL1 and MSL2, inserts were crossed to w/Y; msl-2
1 cn/þ;[ w þ Hsp83
MSL1] [wþHsp83 MSL2]/TM6 males and non-tubby males selected for
analysis. The analysis in the msl-3
1 and mof
1 mutant background
involved generating stocks carrying both the DBF inserts ([wþ DBF])
andmslallelesandtheinsertfortheexpressionof MSL2.Insertsonthe
third chromosome were recombined with the msl-3
1 allele and non-
tubby female larvae from the following cross selected: w/Y; msl-3
1
[wþDBF]/TM6xw/w;msl-3
1[wþHsp83MSL2].Forinsertsonthesecond
chromosome, non-tubby female larvae from the cross w/Y; [wþ DBF];
msl-3
1 [wþ Hsp83 MSL2]/TM6 x w/w; msl-3
1 [wþ Hsp83 MSL2] were
selected.Togeneratethemof
1mutantbackground,theDBFinsertsand
theHsp83 MSL2 werecombined with the mof
1 allele.For inserts on the
third chromosome, non-tubby female larvae from the cross mof
1/Y;
mof
þt6.8/þ;[ w þDBF]/TM6 x mof
1/mof
1;þ;[ w þHsp83 MSL2]/(TM6) were
selected. The absence of the mof
þt6.8 rescue construct and the mof
phenotype was conﬁrmed after staining with anti-MSL1 antibodies.
For inserts on the second chromosome, female larvae from the cross
mof
1/Y;mof
þt6.8/[wþDBF];þxmof
1/mof
1;þ;[w þHsp83MSL2]/(TM6)were
selected. In this case, the absence of the mof þt6.8 rescue construct also
selected for the presence of the insert.
FISH, immunostaining, and immuno-FISH to polytene chromo-
somes. Probes for DNA FISH were prepared with the Prime-It II kit
(Stratagene) using up to 500 ng of DNA template and a mixture of
biotinylated ATP (biotin14dATP) and dATP. For immunostaining,
one of two afﬁnity-puriﬁed rabbit anti-MSL1 antibodies kindly
provided by M. Kuroda [31] and E. Schulze [56] were used at a
dilution of 1:200 and 1:400, respectively. DNA was stained with
Hoechst 33258.
Preparation of polytene chromosomes was carried out as described
[57] with these modiﬁcations: For FISH, glands were ﬁxed in 45%
acetic acid for 5.5 min; for immunostaining and immuno-FISH,
glands were ﬁxed in 1.85% formaldehyde (from frozen stocks) in 45%
acetic acid for 10 min and 6 min, respectively. After freezing, slides
for FISH were washed in 95% ethanol, air dried, and stored at room
temperature; slides for immunostaining and immuno-FISH were
washed in PBS and used immediately, or in the case of immunostain-
ing only, stored in 100% methanol for up to 1 wk.
For FISH, slides were pre-treated by incubation in 23SSC at 65 8C
for 45–60 min, dehydrated in 70% ethanol (2 3 5 min) and 95%
ethanol (2 3 5 min), and air dried. Denaturation was done in 0.07 M
NaOH for 3 min followed by several washes in 23 SSC and
dehydration as above. After precipitation, probes were resuspended
in 100–150 ll of hybridization buffer (50% formamide, 10% dextran
sulphate, 0.6 mg/ml denatured salmon sperm DNA, 23 SSC) and
denatured at 95 8C for 6 min. Slides were incubated overnight with
15–20 ll of hybridization solution at 37 8C in a humid chamber.
Following washing with 23 SSC at 428C( 33 5 min) and PBS, 0.1%
triton at 22 8C( 23 5 min), detection was performed using Cy2-
labelled Streptavidin (1:100) in PBS, 0.1% triton, 1% BSA for 60 min
at 22 8C. Slides were washed in PBS (335 min), stained with Hoechst
(0.4 lg/ml for 2 min) and mounted in 50% glycerol, 0.1 M n-propyl-
gallate in PBS.
For immunostaining, slides were blocked in PBS, 0.1% triton, 1%
BSA for 60 min and incubated overnight at 4 8C with the primary
antibody (in PBS, 0.1% triton, 1% BSA). After washing in PBS and
PBS, 0.1% triton, 1% BSA, detection was performed using Cy3
conjugated anti-rabbit antibody for 60 min at 22 8C. Slides were
washed, stained with Hoechst, and mounted as above.
For immuno-FISH, the immunostaining was performed ﬁrst as
described above. The quality of the immunostaining and the correct
phenotype were conﬁrmed by microscopy. The cover slips were
washed off in PBS, and after an additional washing step, the slides
were transferred to 23SSC and incubated at 70 8C for a maximum of
45 min and the FISH performed as described above. This protocol
will preserve the anti-MSL1 staining, although the signal becomes
much weaker.
Bioinformatics. References for sequences used are as follows:
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Targeting Dosage CompensationroX1-c3 [58]; roX1 DHS: bp 981-1281 of roX1-c3; roX2–78.13 [44];
roX2 DHS: bp 983-1252 of roX2–78.13; 18D10 [37]; control 2L:
2L:1556825..1609283; and control 3R: 3R:15497200..15524289. Acces-
sion numbers for DBF sequences can be found in Table 1. Initial
search for words, N ¼ 6–10, was performed by complete listing of all
nucleotide combinations in roX1 and roX2 DHS fragments. ‘‘Families’’
of words were created by allowing all possible mismatches deﬁned as
follows: 6 bp and 7 bp words were allowed one mismatch, 8 bp and 9
bp words were allowed two, and 10 bp words were allowed three
mismatches. The high-afﬁnity fragments were then searched for all
possible words and word families. Those words or word families
present in at least six out of eight fragments were called ‘‘elements.’’
The list of elements was used to identify 657 element pairs with the
following speciﬁcations: Elements of a pair have to reside within a 5
to 200 bp window, be present in at least six out of eight fragments,
and be absent from control sequences. Pairs related to each other
were identiﬁed and merged by superimposition. Superimpositions of
pairs were calculated from direct and diagonal superimpositions of
the original 657 pairs, allowing variation in individual elements of up
to two positions. Where the word lengths within a family differed, the
number of mismatches was calculated as the minimal number of
mismatches between the shortest word and all possible subsequences
(of equal lengths to that of the shortest word) within the longer
words. Only superimpositions that were present in a higher number
of high-afﬁnity sites than the individual components they are made of
were included in the ﬁnal list of 61 pairs.
The frequency of occurrences of the pairs of elements in the
genome was calculated using sequences from release 3.2 of the
Berkeley Drosophila Genome Project (BDGP) (downloaded from
http://feb2005.archive.ensembl.org/Download; Drosophila_
melanogaster.BDGP3.2.1.feb.dna.chromosome.2L.fa.gz, etc.). The
number of occurrences (N) of each pair was determined for each of
the six chromosome arms: X, 2L, 2R, 3L, 3R, and 4, and normalized by
the length of the chromosome (L). The standard deviation is equal to
the square root of N normalized by L. The enrichment on the X is
signiﬁcant when the fraction N/L is more than three standard
deviations higher compared to the fraction for another chromosome
arm. Enrichment on the X over all ﬁve of the other chromosome arms
was deﬁned as overall signiﬁcant enrichment. The percentage of
occurrences on the X was calculated as the percentage of total
occurrences on all chromosome arms. The frequency of occurrence
in high- versus moderate- and low-afﬁnity elements was calculated by
determining the total number of occurrences in each set of fragments
divided by the total number of kilobases.
DNA sequence logos were made online using the WebLogo
software (version 2.8.1) at http://weblogo.cbr.nrc.ca. All words in
related elements from the speciﬁed pairs presented in Table S1 were
aligned to generate the logos.
Supporting Information
Table S1. Pairs of Elements in High-Afﬁnity DBFs with Signiﬁcant
Enrichment on the X
Found at DOI: 10.1371/journal.pgen.0020005.st001 (92 KB DOC).
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